ABEO today
$2.30-$0.16 (-6.31%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $8.45
Key levels
Resistance$3.05
Resistance$2.65
Support$2.24
Latest news & SEC filings
DealAbeona Therapeutics buys late-stage drug candidate and raises $30 million in equity
All ABEO news →About Abeona Therapeutics
Abeona Therapeutics develops and sells cell and gene treatments for severe illnesses. Its approved therapy, ZEVASKYN, uses a patient's own modified skin cells to treat wounds caused by recessive dystrophic epidermolysis bullosa, and is given at specialized treatment sites in the United States. The company also works on gene therapies delivered with AAV vectors for inherited eye disorders, and makes its products at a facility in Cleveland, Ohio.
Based on the company's 10-K filed Mar 17, 2026.
Nasdaq · Healthcare
ABEONA THERAPEUTICS INC. (ABEO)
What Is the Price Target for ABEO?
SEPT Low Target
$17.00
SEPT Mid Target
$20.50
SEPT High Target
$30.00
Analyst Consensus
$20.50
Is ABEO a Buy or Sell Right Now?
Thesis
- •Revenue growing 66.3% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ABEO.
Start Free Trial →Is ABEO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$16.75
36
Moat Score
NONE
5/9
Piotroski Score
-2.5
Altman Z-Score
What Is Smart Money Doing with ABEO?
Insider Signal
SELLING
0 buys / 18 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Seshadri Vishwas | director officer | Sale | 19,608 | $101K | Sep 29, 2026 |
| Vazzano Joseph Walter | officer | Sale | 9,191 | $47K | Sep 29, 2026 |
| O'Malley Brendan M. | officer | Sale | 6,727 | $35K | Sep 29, 2026 |
| Vasanthavada Madhav | officer | Sale | 4,902 | $25K | Sep 29, 2026 |
| Alvino Mark | director | Sale | 15,000 | $88K | Sep 1, 2026 |
| Silverstein Christine Berni | director | Sale | 18,160 | $104K | Jun 15, 2026 |
| Vazzano Joseph Walter | officer | Sale | 13,421 | $71K | Jun 9, 2026 |
| Vazzano Joseph Walter | officer | Sale | 25,646 | $138K | Jun 9, 2026 |
| Vasanthavada Madhav | officer | Sale | 5,450 | $29K | Jun 9, 2026 |
| Seshadri Vishwas | director officer | Sale | 31,916 | $169K | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ABEO Growth Story
Revenue YoY
66.3%
3yr Revenue CAGR
24.7%
EPS Growth YoY
165.16%
FCF Growth YoY
-44.2%
Revenue Trend
ACCELERATING
Dark Pool Trades for ABEO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ABEO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:03:08 | $2.36 | 1,248 | $$3K | SELL |
| 19:01:17 | $2.36 | 1,851 | $$4K | SELL |
| 18:49:44 | $2.37 | 1,000 | $$2K | BUY |
| 18:49:32 | $2.38 | 1,500 | $$4K | SELL |
| 18:36:26 | $2.38 | 1,000 | $$2K | SELL |
5 dark pool trades shown · $$16K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ABEO
PREVIEWSEPT Investing provides real-time options flow tracking for ABEO, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2 | Jan 15 | 65 | $$120 | 2 | SWEEP |
| CALL | $2 | Jun 17 | 218 | $$5600 | 80 | SWEEP |
| CALL | $2 | Jun 17 | 218 | $$980 | 14 | SWEEP |
| CALL | $2 | Jun 17 | 218 | $$13.5K | 195 | BLOCK |
| CALL | $2 | Jun 17 | 218 | $$7500 | 100 | BLOCK |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ABEONA THERAPEUTICS INC. (ABEO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ABEO — frequently asked questions
What is ABEO stock price today?
ABEONA THERAPEUTICS INC. (ABEO) is at $2.30, down 6.31% (-$0.16) at the Nov 11, 2026 close.
Why is ABEO stock moving today?
Latest ABEO news — Nov 9, 2026: Abeona Therapeutics buys late-stage drug candidate and raises $30 million in equity
What is the ABEO price target?
The average analyst price target for ABEO is $20.50, ranging from $17 to $30, based on 4 analysts. Latest: Cantor Fitzgerald maintains on Sep 18, 2026.
What do analysts rate ABEO?
Analyst ratings for ABEO: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did ABEO beat earnings?
ABEO last reported on Aug 13, 2026: EPS -$0.35 vs -$0.23 expected — a miss of 51.1%.
Does ABEO pay a dividend?
ABEO does not currently pay a dividend.
How much debt does ABEO have?
ABEONA THERAPEUTICS INC. reported $15M of debt and $56M of cash (Jun 30, 2026).
What are ABEO support and resistance levels?
Support: $2.24. Resistance: $2.65, $3.05, $3.41.
What are insiders doing with ABEO?
Insider activity: SELLING, 0 buys and 18 sells in the last 90 days.
What is the latest news on ABEO?
Nov 9, 2026: Abeona Therapeutics buys late-stage drug candidate and raises $30 million in equity